1.16
price up icon8.41%   0.09
after-market Handel nachbörslich: 1.16
loading
Schlusskurs vom Vortag:
$1.07
Offen:
$1.05
24-Stunden-Volumen:
68,173
Relative Volume:
0.68
Marktkapitalisierung:
$64.38M
Einnahmen:
$33.79M
Nettoeinkommen (Verlust:
$-18.67M
KGV:
-3.2384
EPS:
-0.3582
Netto-Cashflow:
$-19.17M
1W Leistung:
+12.62%
1M Leistung:
+12.62%
6M Leistung:
+10.48%
1J Leistung:
+41.17%
1-Tages-Spanne:
Value
$1.05
$1.16
1-Wochen-Bereich:
Value
$1.01
$1.16
52-Wochen-Spanne:
Value
$0.70
$1.61

Cytosorbents Corp Stock (CTSO) Company Profile

Name
Firmenname
Cytosorbents Corp
Name
Telefon
973-329-8885
Name
Adresse
305 COLLEGE ROAD EAST, PRINCETON, NJ
Name
Mitarbeiter
149
Name
Twitter
@CytoSorbents
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
CTSO's Discussions on Twitter

Vergleichen Sie CTSO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
CTSO
Cytosorbents Corp
1.16 64.38M 33.79M -18.67M -19.17M -0.3582
Medical Devices icon
ABT
Abbott Laboratories
129.38 227.16B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
101.14 140.69B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
361.05 132.32B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
84.30 105.94B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
75.13 41.90B 5.72B 4.17B 259.90M 6.97

Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-09-07 Eingeleitet B. Riley Securities Buy
2021-10-14 Fortgesetzt B. Riley Securities Buy
2020-09-17 Eingeleitet Jefferies Buy
2020-09-01 Eingeleitet SVB Leerink Outperform
2017-08-08 Bestätigt Maxim Group Buy
2016-10-26 Eingeleitet Aegis Capital Buy
2016-05-24 Eingeleitet Maxim Group Buy
2015-10-29 Hochstufung WBB Securities Speculative Buy → Buy
2015-05-12 Bestätigt MLV & Co Buy
2015-04-01 Bestätigt MLV & Co Buy
2015-03-05 Eingeleitet MLV & Co Buy
2015-02-25 Eingeleitet WBB Securities Speculative Buy
2015-01-27 Bestätigt H.C. Wainwright Buy
Alle ansehen

Cytosorbents Corp Aktie (CTSO) Neueste Nachrichten

pulisher
Apr 21, 2025

CytoSorbents secures $1.7M via NJ tax credit transfer - Investing.com

Apr 21, 2025
pulisher
Apr 21, 2025

CytoSorbents Lands $1.7M Strategic Funding: New DrugSorb Product Launch and Manufacturing Expansion Ahead - Stock Titan

Apr 21, 2025
pulisher
Apr 19, 2025

Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller - PR Newswire

Apr 17, 2025
pulisher
Apr 14, 2025

Cytosorbents Appoints Thomas Shannon As Vice President Of Marketing For North America - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

Strategic Hire: Medtronic $450M Portfolio Leader Joins CytoSorbents to Drive Breakthrough Device Launch - Stock Titan

Apr 14, 2025
pulisher
Apr 13, 2025

Raymond James Financial Inc. Takes Position in Cytosorbents Co. (NASDAQ:CTSO) - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - Defense World

Apr 11, 2025
pulisher
Apr 07, 2025

Analysts Offer Predictions for Cytosorbents Q1 Earnings - Defense World

Apr 07, 2025
pulisher
Apr 07, 2025

Brokers Offer Predictions for Cytosorbents Q1 Earnings - Defense World

Apr 07, 2025
pulisher
Apr 05, 2025

Analysts Set Expectations for Cytosorbents FY2028 Earnings - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

Cytosorbents (NASDAQ:CTSO) Earns “Neutral” Rating from HC Wainwright - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

CytoSorbents extends Series B Warrants expiration to June 10 - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Cytosorbents CorpExtends Expiration Date Of Series B Right Warrants To June 10, 2025SEC Filing - MarketScreener

Apr 04, 2025
pulisher
Apr 04, 2025

CytoSorbents extends Series B Warrants expiration to June 10 By Investing.com - Investing.com UK

Apr 04, 2025
pulisher
Apr 04, 2025

CytoSorbents Gives Investors More Time: Series B Warrants Now Extended to June 2025 - Stock Titan

Apr 04, 2025
pulisher
Apr 03, 2025

Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Cytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral Capital - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Cytosorbents Corp Reports Strong Growth Amid Challenges - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

CytoSorbents Corp Q4 2024 Earnings: EPS Misses at -$0.06, Revenue Falls Short at $9.2 Million - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

The Analyst Verdict: CytoSorbents In The Eyes Of 4 Experts - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Cytosorbents Corporation (NASDAQ:CTSO) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

CytoSorbents: Q4 Earnings Snapshot - CT Insider

Apr 01, 2025
pulisher
Apr 01, 2025

CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Stron - GuruFocus

Apr 01, 2025
pulisher
Mar 31, 2025

CytoSorbents Corporation Reports Strong 2024 Performance - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Cytosorbents Crp Q4 2024 beats EPS forecast By Investing.com - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

CTSOCytosorbents Corp Latest Stock News & Market Updates - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Cytosorbents Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Cytosorbents Corp SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

CYTOSORBENTS Earnings Results: $CTSO Reports Quarterly Earnings - Nasdaq

Mar 31, 2025
pulisher
Mar 28, 2025

Cytosorbents (CTSO) Expected to Post Improved Earnings and Reven - GuruFocus

Mar 28, 2025
pulisher
Mar 28, 2025

Insights into CytoSorbents's Upcoming Earnings - Benzinga

Mar 28, 2025
pulisher
Mar 24, 2025

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What t - GuruFocus.com

Mar 24, 2025
pulisher
Mar 24, 2025

Cytosorbents (CTSO) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

CytoSorbents Corp (CTSO) Reports Q4 Revenue Between $9.0M and $9 - GuruFocus

Mar 23, 2025
pulisher
Mar 21, 2025

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit - Longview News-Journal

Mar 21, 2025
pulisher
Mar 21, 2025

CytoSorbents Q4 Revenue Jumps 25% Despite Earnings DelayKey Metrics Released - StockTitan

Mar 21, 2025
pulisher
Mar 18, 2025

Cytosorbents (NASDAQ:CTSO) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World

Mar 18, 2025
pulisher
Mar 10, 2025

CytoSorbents Stock Price, Quotes and Forecasts | NASDAQ:CTSO - Benzinga

Mar 10, 2025
pulisher
Mar 10, 2025

Cytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years ago - Yahoo Finance

Mar 10, 2025
pulisher
Mar 10, 2025

StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World

Mar 10, 2025
pulisher
Mar 06, 2025

CytoSorbents Corp. to Host Earnings Call - ACCESS Newswire

Mar 06, 2025
pulisher
Mar 05, 2025

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What T - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Mar 05, 2025
pulisher
Mar 04, 2025

Cytosorbents Corp Reaffirms Preliminary Financial Expectations For Q4 And FY 2024 -March 04, 2025 at 04:52 pm EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

CytoSorbents delays earnings call after VP’s passing - Investing.com India

Mar 04, 2025

Finanzdaten der Cytosorbents Corp-Aktie (CTSO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$101.50
price up icon 2.06%
medical_devices PHG
$24.72
price up icon 1.06%
medical_devices STE
$226.35
price up icon 1.11%
$70.78
price up icon 5.86%
$67.08
price up icon 3.37%
medical_devices EW
$75.13
price up icon 6.63%
Kapitalisierung:     |  Volumen (24h):